DE60226411D1 - Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese - Google Patents

Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese

Info

Publication number
DE60226411D1
DE60226411D1 DE60226411T DE60226411T DE60226411D1 DE 60226411 D1 DE60226411 D1 DE 60226411D1 DE 60226411 T DE60226411 T DE 60226411T DE 60226411 T DE60226411 T DE 60226411T DE 60226411 D1 DE60226411 D1 DE 60226411D1
Authority
DE
Germany
Prior art keywords
peptide
protein
compositions
peptidomimetic synthesis
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226411T
Other languages
German (de)
English (en)
Inventor
Anthony C Forster
Stephen C Blacklow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forster Anthony C Brentwood Tenn Us
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60226411D1 publication Critical patent/DE60226411D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1062Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60226411T 2001-01-25 2002-01-25 Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese Expired - Lifetime DE60226411D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26414701P 2001-01-25 2001-01-25
PCT/US2002/002344 WO2002059293A2 (en) 2001-01-25 2002-01-25 Process and compositions for peptide, protein and peptidomimetic synthesis

Publications (1)

Publication Number Publication Date
DE60226411D1 true DE60226411D1 (de) 2008-06-19

Family

ID=23004801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60226411T Expired - Lifetime DE60226411D1 (de) 2001-01-25 2002-01-25 Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese

Country Status (7)

Country Link
US (1) US6977150B2 (https=)
EP (1) EP1356036B1 (https=)
JP (2) JP2004531225A (https=)
AT (1) ATE394482T1 (https=)
CA (1) CA2435812C (https=)
DE (1) DE60226411D1 (https=)
WO (1) WO2002059293A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4061043B2 (ja) 2000-12-28 2008-03-12 株式会社ポストゲノム研究所 invitro転写/翻訳系によるペプチド等の製造方法
AU2003225085A1 (en) * 2002-04-19 2003-11-03 California Institute Of Technology Unnatural amino acid containing display libraries
WO2004110964A2 (en) * 2003-06-16 2004-12-23 Nuevolution A/S Encoded molecules by translation (emt)
EP2327724A3 (en) 2004-02-02 2011-07-27 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
WO2007139573A1 (en) * 2006-05-31 2007-12-06 The Trustees Of Columbia University In The City Of New York Ribosome and rna display of biologically active small molecules
WO2007140471A2 (en) * 2006-05-31 2007-12-06 The Trustees Of Columbia University In The City Of New York Ribosome and rna display of biologically active small molecules
WO2008005529A2 (en) 2006-07-07 2008-01-10 The Trustees Columbia University In The City Of New York Cell-mediated directed evolution
US9182406B2 (en) 2008-08-04 2015-11-10 Biodesy, Inc. Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
CN102348807B (zh) * 2009-01-12 2015-04-15 苏特罗生物制药公司 利用体外蛋白合成体系将非天然氨基酸引入蛋白的单装载体系
CA2843955A1 (en) 2011-08-01 2013-02-07 The General Hospital Corporation Protein and peptide libraries
JP6421122B2 (ja) 2012-10-12 2018-11-07 ストロ バイオファーマ, インコーポレイテッド 改善された発現のための、細菌抽出物中の選択タンパク質のタンパク質分解不活性化
WO2014189768A1 (en) * 2013-05-19 2014-11-27 The Board Of Trustees Of The Leland Devices and methods for display of encoded peptides, polypeptides, and proteins on dna
WO2015084867A1 (en) 2013-12-02 2015-06-11 Brandeis University Multivalent glycopeptides that tightly bind to target proteins
EP3237906B8 (en) 2014-12-23 2020-10-28 Bluelight Therapeutics, Inc. Attachment of proteins to interfaces for use in nonlinear optical detection
EP3274459A4 (en) * 2015-03-27 2018-08-22 The University of Queensland Platform for non-natural amino acid incorporation into proteins
US11174479B2 (en) 2018-08-13 2021-11-16 The Board Of Trustees Of The Leland Stanford Junior University Devices and methods for display of encoded peptides, PolyPeptides, and proteins on DNA
BR112022002365A2 (pt) 2019-08-09 2022-04-26 Nutcracker Therapeutics Inc Métodos e aparelhos para fabricar e para remover material de uma composição terapêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8124694A (en) 1993-10-29 1995-05-22 Affymax Technologies N.V. In vitro peptide and antibody display libraries
US5643722A (en) * 1994-05-11 1997-07-01 Trustees Of Boston University Methods for the detection and isolation of proteins
JP4061043B2 (ja) * 2000-12-28 2008-03-12 株式会社ポストゲノム研究所 invitro転写/翻訳系によるペプチド等の製造方法

Also Published As

Publication number Publication date
EP1356036A2 (en) 2003-10-29
WO2002059293A3 (en) 2003-05-30
CA2435812C (en) 2012-03-27
WO2002059293A2 (en) 2002-08-01
US6977150B2 (en) 2005-12-20
JP2010259440A (ja) 2010-11-18
ATE394482T1 (de) 2008-05-15
US20040091955A1 (en) 2004-05-13
AU2002255488A2 (en) 2002-08-06
JP4972191B2 (ja) 2012-07-11
CA2435812A1 (en) 2002-08-01
EP1356036B1 (en) 2008-05-07
JP2004531225A (ja) 2004-10-14

Similar Documents

Publication Publication Date Title
DE60226411D1 (de) Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese
ATE290014T1 (de) Festphasen-peptidsynthese
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
SI2174946T1 (sl) Metode za kemično sintetiziranje himernih proteinov imunoglobulina
WO2004113493A3 (en) Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
EP1484339A3 (en) Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
EP2279753A3 (en) Remodeling and glycoconjugation of peptides
ATE454447T1 (de) Peptidagonisten für prostata-spezifisches antigen und ihre verwendung
PL344752A1 (en) Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
TW200510528A (en) Polypeptide inducing apoptosis
ATE170192T1 (de) Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden
FI961044A7 (fi) Kininogeeni-inhibiittorit
YU394A (sh) Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu
SE9503679D0 (sv) Antioxidants
BR0312889A (pt) Polipeptìdeo t20 peguilado
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
WO2003104266A3 (en) PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
ATE314474T1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
DE69504795D1 (de) Methoden zur synthese und reinigung von peptiden
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: FORSTER, ANTHONY C., BRENTWOOD, TENN., US

8364 No opposition during term of opposition